<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32756504</article-id>
<article-id pub-id-type="pmc">7432054</article-id>
<article-id pub-id-type="doi">10.3390/ijms21155564</article-id>
<article-id pub-id-type="publisher-id">ijms-21-05564</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Early Transcriptomic Changes upon Thalidomide Exposure Influence the Later Neuronal Development in Human Embryonic Stem Cell-Derived Spheres</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kikegawa</surname>
<given-names>Mami</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-05564">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0110-6849</contrib-id>
<name>
<surname>Qin</surname>
<given-names>Xian-Yang</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-21-05564">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ito</surname>
<given-names>Tomohiro</given-names>
</name>
<xref ref-type="aff" rid="af3-ijms-21-05564">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nishikawa</surname>
<given-names>Hiromi</given-names>
</name>
<xref ref-type="aff" rid="af4-ijms-21-05564">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nansai</surname>
<given-names>Hiroko</given-names>
</name>
<xref ref-type="aff" rid="af3-ijms-21-05564">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7162-6455</contrib-id>
<name>
<surname>Sone</surname>
<given-names>Hideko</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-05564">1</xref>
<xref ref-type="aff" rid="af3-ijms-21-05564">3</xref>
<xref ref-type="aff" rid="af5-ijms-21-05564">5</xref>
<xref ref-type="corresp" rid="c1-ijms-21-05564">*</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-21-05564"><label>1</label>Laboratory of Kampo Pharmacology, Yokohama University of Pharmacy, Yokohama 245-0066, Japan; <email>m.takigawa@hamayaku.ac.jp</email></aff>
<aff id="af2-ijms-21-05564"><label>2</label>Liver Cancer Prevention Research Unit, RIKEN Cluster for Pioneering Research, Wako, Saitama 351-0198, Japan; <email>xyqin@riken.jp</email></aff>
<aff id="af3-ijms-21-05564"><label>3</label>Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Tsukuba, Ibaraki 305-8506, Japan; <email>itotomo@nies.go.jp</email> (T.I.); <email>zahahi@yahoo.co.jp</email> (H.N.)</aff>
<aff id="af4-ijms-21-05564"><label>4</label>Department of Psychiatry and Behavioral Science, Kanazawa University School of Medicine, Kanazawa, Ishikawa 920-0942, Japan; <email>hiromi.a.rac@gmail.com</email></aff>
<aff id="af5-ijms-21-05564"><label>5</label>Environmental Health and Prevention Research Unit, Yokohama University of Pharmacy, Yokohama 245-0066, Japan</aff>
<author-notes>
<corresp id="c1-ijms-21-05564"><label>*</label>Correspondence: <email>hideko.sone@yok.hamayaku.ac.jp</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>8</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>8</month>
<year>2020</year>
</pub-date>
<volume>21</volume>
<issue>15</issue>
<elocation-id>5564</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>6</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>7</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 by the authors.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Stress in early life has been linked with the development of late-life neurological disorders. Early developmental age is potentially sensitive to several environmental chemicals such as alcohol, drugs, food contaminants, or air pollutants. The recent advances using three-dimensional neural sphere cultures derived from pluripotent stem cells have provided insights into the etiology of neurological diseases and new therapeutic strategies for assessing chemical safety. In this study, we investigated the neurodevelopmental effects of exposure to thalidomide (TMD); 2,2′,4,4′-tetrabromodiphenyl ether; bisphenol A; and 4-hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl using a human embryonic stem cell (hESC)-derived sphere model. We exposed each chemical to the spheres and conducted a combinational analysis of global gene expression profiling using microarray at the early stage and morphological examination of neural differentiation at the later stage to understand the molecular events underlying the development of hESC-derived spheres. Among the four chemicals, TMD exposure especially influenced the differentiation of spheres into neuronal cells. Transcriptomic analysis and functional annotation identified specific genes that are TMD-induced and associated with ERK and synaptic signaling pathways. Computational network analysis predicted that TMD induced the expression of DNA-binding protein inhibitor ID2, which plays an important role in neuronal development. These findings provide direct evidence that early transcriptomic changes during differentiation of hESCs upon exposure to TMD influence neuronal development in the later stages.</p>
</abstract>
<kwd-group>
<kwd>thalidomide</kwd>
<kwd>environmental chemicals</kwd>
<kwd>neuronal differentiations</kwd>
<kwd>human embryonic stem cells</kwd>
<kwd>computational network analysis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-21-05564" sec-type="intro">
<title>1. Introduction</title>
<p>There has been worldwide concern over the increasing number of patients with depression and children with developmental disorders [<xref ref-type="bibr" rid="B1-ijms-21-05564">1</xref>,<xref ref-type="bibr" rid="B2-ijms-21-05564">2</xref>]. Recent studies suggest that the increasing prevalence of developmental disability in children is due to not only genetic factors but also some environmental factors [<xref ref-type="bibr" rid="B3-ijms-21-05564">3</xref>]. Environmental factors including exposure to chemicals such as pesticides and air pollutants during the developmental age could play a role in the development of neurodevelopmental diseases [<xref ref-type="bibr" rid="B4-ijms-21-05564">4</xref>,<xref ref-type="bibr" rid="B5-ijms-21-05564">5</xref>]. In addition, the developing brain has been shown to be more sensitive to environmentally hazardous chemicals than the adult brain [<xref ref-type="bibr" rid="B6-ijms-21-05564">6</xref>,<xref ref-type="bibr" rid="B7-ijms-21-05564">7</xref>]. Recent studies indicate that in vitro models are starting to replace traditional in vivo models for evaluation of the effects of external substances on fetuses and for the assessment of neurotoxicity to chemical exposure; this alternative approach can bridge the mechanistic gap between humans and animals and can be used to elucidate new therapeutic approaches [<xref ref-type="bibr" rid="B8-ijms-21-05564">8</xref>,<xref ref-type="bibr" rid="B9-ijms-21-05564">9</xref>,<xref ref-type="bibr" rid="B10-ijms-21-05564">10</xref>]. Therefore, systems using human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) have been developed to directly predict human risks; the development of these systems would provide important information to elucidate the neurodevelopmental toxicities of numerous environmental chemicals.</p>
<p>We previously developed in vitro models using hESCs for studying the neurodevelopmental toxicities caused by various environmental pollutants [<xref ref-type="bibr" rid="B11-ijms-21-05564">11</xref>,<xref ref-type="bibr" rid="B12-ijms-21-05564">12</xref>,<xref ref-type="bibr" rid="B13-ijms-21-05564">13</xref>]. Our previous work also showed that thalidomide (TMD) inhibits the development of dopaminergic neurons from neuronal progenitor cells [<xref ref-type="bibr" rid="B14-ijms-21-05564">14</xref>]. Anti-depressant-like effects of maternal exposure to TMD was also observed in mice [<xref ref-type="bibr" rid="B15-ijms-21-05564">15</xref>,<xref ref-type="bibr" rid="B16-ijms-21-05564">16</xref>]. Early exposure to TMD in the pregnant period caused developmental abnormality in the human brain [<xref ref-type="bibr" rid="B17-ijms-21-05564">17</xref>,<xref ref-type="bibr" rid="B18-ijms-21-05564">18</xref>]. TMD is currently used to treat multiple myeloma, while it is a known teratogen and neurodevelopmental toxicant. Although it was recently shown that the degradation of spalt-like transcription factor 4 (SALL4) may be an essential component of TMD-induced teratogenicity that causes severe birth defects in the fetus [<xref ref-type="bibr" rid="B19-ijms-21-05564">19</xref>,<xref ref-type="bibr" rid="B20-ijms-21-05564">20</xref>], this mechanism is not enough to explain developmental neurotoxicity of TMD observed in in vitro and in vivo experiments. In addition, 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47), bisphenol A (BPA), and 4-hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl (4OH-PCB187) were also included in this study in comparison to TMD, since they show a high association with neuronal developmental disorders in epidemiologic studies and in animal and cellular experiments [<xref ref-type="bibr" rid="B21-ijms-21-05564">21</xref>,<xref ref-type="bibr" rid="B22-ijms-21-05564">22</xref>,<xref ref-type="bibr" rid="B23-ijms-21-05564">23</xref>,<xref ref-type="bibr" rid="B24-ijms-21-05564">24</xref>]. Grandjean and Landrigan suggested polybrominated diphenyl ethers (PBDEs) as one group of newly recognized developmental neurotoxicants including organophosphate pesticides, herbicides, fungicides and manganese. Bisphenol A is also suggested as another suspected developmental neurotoxicant [<xref ref-type="bibr" rid="B25-ijms-21-05564">25</xref>]. 4OH-PCB187 is one of main metabolites for PCBs and they concentration was found in blood at a higher concentration, rather than other congeners [<xref ref-type="bibr" rid="B26-ijms-21-05564">26</xref>]. PCB and their metabolites are very similar to the structures of PBDEs and their hydroxyl metabolites [<xref ref-type="bibr" rid="B27-ijms-21-05564">27</xref>].</p>
<p>Collectively, to understand the molecular events underlying the neurodevelopmental effects of environmental chemicals including drugs, endocrine disruptors, and flame retardants, we have studied the effects of TMD and three environmental pollutants including BDE-47, BPA, and 4OH-PCB187 on global gene expression during neurosphere formation and during the following differentiation into neuronal cells.</p>
</sec>
<sec id="sec2-ijms-21-05564" sec-type="results">
<title>2. Results and Discussion</title>
<sec id="sec2dot1-ijms-21-05564">
<title>2.1. Morphological Analysis of the Effect of Chemical Exposure at the Early Stage of Development on the Neuronal Differentiation from hESC-Derived Spheres</title>
<p>In order to investigate the neurodevelopmental effects, we generated a protocol for sphere formation from hESCs and differentiation to neuronal cells (<xref ref-type="fig" rid="ijms-21-05564-f001">Figure 1</xref>A). In this model, we confirmed the differentiation of spheres into neuronal cells on Day 28 by immunostaining with anti-microtubule-associated protein 2 (MAP2) and anti-tyrosine hydroxylase (TH) antibodies (<xref ref-type="app" rid="app1-ijms-21-05564">Figure S1A</xref>). Next, we exposed the spheres to each chemical, and examined the effects of chemical exposure on differentiation potency. Our results showed that TMD significantly increased the total cell numbers, and the presence of MAP2-positive and TH-positive neuronal cells in a dose-dependent manner (<xref ref-type="fig" rid="ijms-21-05564-f001">Figure 1</xref>B and <xref ref-type="app" rid="app1-ijms-21-05564">Figure S1A</xref>). Slight induction of TH-positive cells but not MAP2-positive cells was observed with exposure to 10<sup>−8</sup> M BDE-47 (<xref ref-type="fig" rid="ijms-21-05564-f001">Figure 1</xref>C). No adverse effects were observed upon exposure to BPA and 4OH-PCB187 (<xref ref-type="fig" rid="ijms-21-05564-f001">Figure 1</xref>D,E, respectively). Furthermore, the normalized MAP2-positive area and TH-positive area with the total cell number showed that the neuronal differentiation-promoting effect was only observed with TMD (<xref ref-type="app" rid="app1-ijms-21-05564">Figure S1B</xref>). However, there was no significant change in TH/MAP2 ratio, which may be due to the promotion of nervous system differentiation or the expansion of the sphere itself. At that expansion stage, the TMD-treated cells in spheres may not be involved in promoting or suppressing the differentiation of TH.</p>
<p>The increase in number of neuronal cells upon TMD exposure was not consistent with another study that has investigated high-concentration exposure of this chemical [<xref ref-type="bibr" rid="B28-ijms-21-05564">28</xref>]. These results indicate that the early exposure to TMD in vitro promotes neuronal development at a later stage of hESCs, contrary to previous reports that hESC-derived neuronal progenitor cells were exposed at the later stage [<xref ref-type="bibr" rid="B14-ijms-21-05564">14</xref>]. The increase in TH-neuronal cells in the BDE-47 exposure was consistent with another study that the similar dose range of BDE-47 slightly increased the TUBB3 expression associated with dopaminergic neuron [<xref ref-type="bibr" rid="B29-ijms-21-05564">29</xref>]. These results highlighted the importance to evaluate risk of environmental chemicals, such as the effect on neuronal development, in the hESC-derived sphere model at realistic blood concentration levels and timing of exposure.</p>
</sec>
<sec id="sec2dot2-ijms-21-05564">
<title>2.2. Transcriptional Analysis of the Effect of Chemical Exposure at the Early Stage of Neuronal Development Derived from hESCs</title>
<p>Next, to explore the molecular mechanism underlying the effects of chemical exposure on the differentiation of hESCs, we performed microarray-based transcriptome analysis to examine the global gene expression changes at the sphere stage (on Day 7). The chemical concentration for the microarray analysis was determined according to the results of the morphological analysis. For BPA and PCB, the highest concentrations were chosen since there were no significant effects at any concentration. For TMD and BDE, the lowest observed effect concentrations were chosen. Each chemical induced the changes of gene expression at a comparable level. For this comparison, only genes with a fold change of more than two compared to vehicle control were considered (<xref ref-type="fig" rid="ijms-21-05564-f002">Figure 2</xref>A). Further, exposure to different chemicals showed that there are similar functional annotations of differentially expressed genes (<xref ref-type="fig" rid="ijms-21-05564-f002">Figure 2</xref>B). The percentage of differentially expressed transcriptional factors was approximately 9% in all chemical cases (<xref ref-type="fig" rid="ijms-21-05564-f002">Figure 2</xref>B). These results suggest that our experimental strategy was able to capture the similar impact of different chemical exposures on transcriptomic changes.</p>
<p>To further understand the functional difference upon each different chemical exposure, the differentially expressed genes were imported into the IPA program. Canonical pathway analysis showed the strongest impact of TMD exposure in regulating multiple biological pathways as compared to other chemicals (<xref ref-type="fig" rid="ijms-21-05564-f002">Figure 2</xref>C). In accordance with the findings in the morphological analysis (<xref ref-type="fig" rid="ijms-21-05564-f001">Figure 1</xref>B), the gene expression of <italic>MAP2</italic> was selectively induced upon TMD exposure (<xref ref-type="app" rid="app1-ijms-21-05564">Figure S1C</xref>). In addition, among the differentially expressed genes induced upon TMD exposure, we could identify an enrichment of genes encoding molecules regulating neuronal functions, such as “nNOS Signaling in Neurons”, “Extrinsic Prothrombin Activation Pathway”, “Circadian Rhythm Signaling”, and “Synaptogenesis Signaling Pathway” (<xref ref-type="fig" rid="ijms-21-05564-f002">Figure 2</xref>C). Gene expression profiling showed that TMD exposure selectively modulated the expression of <italic>CACNB4, CDH6, CPLX3, CREB5, EPHB1, GRIA3, GRIA4, GRIN2A, KALRN, NRXN1, PRKCD, SYT15,</italic> and <italic>SYT4</italic> (<xref ref-type="fig" rid="ijms-21-05564-f002">Figure 2</xref>D and <xref ref-type="app" rid="app1-ijms-21-05564">Figure S2</xref>).</p>
</sec>
<sec id="sec2dot3-ijms-21-05564">
<title>2.3. TMD-Specific Effect on Gene Expression at the Early Stage of Neuronal Development Derived from hESCs</title>
<p>The differentially expressed genes that are induced by TMD but not the other chemicals were selected if they have a fold change higher than the fold change of 2. TMD-specific genes with 377 candidates were selected after the comparison between TMD and each of the three chemicals correspondingly (<xref ref-type="fig" rid="ijms-21-05564-f003">Figure 3</xref>A and <xref ref-type="app" rid="app1-ijms-21-05564">Table S1</xref>) and was imported into IPA for pathway analysis. Interestingly, top network function analysis showed that a wide range of signaling pathways associated with neurological disease and embryonic development were specifically affected by TMD exposure (<xref ref-type="fig" rid="ijms-21-05564-f003">Figure 3</xref>B). The most highly populated network entitled “Neurological Disease, Organismal Injury and Abnormalities, Cell Morphology” indicated the central role of extracellular signal-regulated kinases ERK1/2 in controlling the transcriptional response of hESC-derived sphere in response to TMD exposure (<xref ref-type="fig" rid="ijms-21-05564-f003">Figure 3</xref>C). Further upstream causal network analysis confirmed that TMD might be exerting its neurodevelopmental effect via the suppression of ERK1/2 activation (<xref ref-type="app" rid="app1-ijms-21-05564">Figure S3</xref>). In accordance with our findings in the hESC-derived sphere model, a previous study in the human neural stem cell model showed that inhibition of ERK by chemical inhibitors promoted neuronal generation, especially of TH-positive neurons [<xref ref-type="bibr" rid="B30-ijms-21-05564">30</xref>]. To further understand the neurodevelopmental effect of TMD, the effect of TMD on biological pathways related to embryonic development was evaluated according to the activation z-score, which is a statistical measure in IPA and can be used to predict the activation state (activated or inhibited) of a biological molecule or function based on a statistically significant pattern match of up- and down-regulated gene expression [<xref ref-type="bibr" rid="B31-ijms-21-05564">31</xref>]. Interestingly, the function of “Differentiation of embryonic cells” was predicted to be activated by TMD based on the expression of enriched genes such as FRZB, TET2, CoL12A1, ID2, NRP1, HHEX, IL6ST, RUNX1, KDM2B, NPY1R, FOXA2, NODAL, and ANGPT1 (<xref ref-type="fig" rid="ijms-21-05564-f003">Figure 3</xref>D,E).</p>
</sec>
<sec id="sec2dot4-ijms-21-05564">
<title>2.4. Integrated Network Analysis of Transcriptional and Morphological Changes during Neuronal Differentiation from hESC-Derived Spheres</title>
<p>Finally, integrated network analysis was performed to determine the connection between the genetic and morphological actions of TMD during neuronal differentiation from hESC-derived spheres. Candidate feature genes involved in the function of “Differentiation of embryonic cells” (<xref ref-type="fig" rid="ijms-21-05564-f003">Figure 3</xref>E) with correctly predicted expression patterns in comparison with previous findings in the Ingenuity Knowledge Base were selected for network analysis (<xref ref-type="app" rid="app1-ijms-21-05564">Table S2</xref>). As the result, expression data of four genes (TET2, HHEX, ID2 and NRP1) and two morphological measures of TH and MAP2 staining after chemical exposure were used for network analysis using three approaches: correlation-based network analysis, Bayesian network analysis and physiological network analysis. The correlation network was generated by calculating the Pearson correlation coefficient between each pair of gene and morphological parameters (<xref ref-type="fig" rid="ijms-21-05564-f004">Figure 4</xref>A). Either the four genes or the two morphological measures were correlated with each other. For the relationship between the gene and morphological parameters, NRP1 was correlated with TH and MAP2, while HHEX was correlated with MAP2.</p>
<p>However, a limitation of correlation networks is that they can be confounded by indirect relationships. In contrast, methods that infer the data such as a whole, such as the Bayesian network, includes only direct effects and is considered more biologically interpretable due to removal of indirect correlations [<xref ref-type="bibr" rid="B31-ijms-21-05564">31</xref>]. The integrative Bayesian network showed that the node of a transcriptional regulator ID2 was located at the top of the network hierarchy and was positively related to MAP2 (<xref ref-type="fig" rid="ijms-21-05564-f004">Figure 4</xref>B and <xref ref-type="app" rid="app1-ijms-21-05564">Figure S4</xref>). The enzyme TET2 was not connected to the network, suggesting that the inferred network using a Bayesian algorithm was able to remove indirect relationships. Finally, to verify the biological relevance of the inferred connections, a physiological network was generated based on findings of from previous studies using the Ingenuity Knowledge Base. In accordance with Bayesian network, the physiological network showed that there were no direct relationships between TET2 and the functions of either “Neurogenesis” or “Differentiation of embryonic stem cells”, whereas ID2 was connected to “Neurogenesis” (<xref ref-type="fig" rid="ijms-21-05564-f004">Figure 4</xref>C). It was reported that induction of the ID2 gene expression, which was also observed in hESC-derived sphere after TMD treatment in the present study, increased differentiation of Tuj1 and GFAP-positive neurosphere cells [<xref ref-type="bibr" rid="B32-ijms-21-05564">32</xref>]. Three environmental chemicals other than TMD had very limited or no significant changes in neuronal differentiation in this model. BDE47 has recently been reported to have inhibitory effects on human ES-derived neuronal cells similar to our model [<xref ref-type="bibr" rid="B21-ijms-21-05564">21</xref>,<xref ref-type="bibr" rid="B33-ijms-21-05564">33</xref>]. Similarly, BPA has been found to have suppressive effects on neuronal stem cells [<xref ref-type="bibr" rid="B34-ijms-21-05564">34</xref>,<xref ref-type="bibr" rid="B35-ijms-21-05564">35</xref>]. Regarding OH-PCB187 or mother compounds of PCB, epidemiological studies suggest a negative relationship with IQ and a relationship with ADHD [<xref ref-type="bibr" rid="B36-ijms-21-05564">36</xref>], but no report has been made in vitro. This is the first report of exposure of OH-PCB187 to human ES.</p>
</sec>
</sec>
<sec id="sec3-ijms-21-05564">
<title>3. Materials and Methods</title>
<sec id="sec3dot1-ijms-21-05564">
<title>3.1. Ethics Statement</title>
<p>Experiments using hESCs were approved by the ethics committees of the National Institute for Environmental Studies in accordance with to the guideline of the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Notification number 20 of Ministry of Education, Culture, Sports, Science and Technology No. 857, 10 October 2008). The experimental plan was registered on the NIES ethics committee (Notification number: 2008-1, Reception number: 2007-1, 15 October 2008).</p>
</sec>
<sec id="sec3dot2-ijms-21-05564">
<title>3.2. Chemical Exposures, Culture and Neuronal Differentiation of Human ESCs</title>
<p>Dimethyl sulfoxide (DMSO) and BPA were obtained from Sigma–Aldrich Co. (St. Louis, MO, USA). TMD were obtained from Wako Pure Chemicals (Tokyo, Japan); 4OH-PCB187 and BDE-47 were obtained from AccuStandard (New Haven, CT, USA). DMSO was used as the primary solvent for all chemicals. The final concentrations of DMSO in the media did not exceed 0.1% (<italic>v</italic>/<italic>v</italic>). Human embryonic stem cells (khES3) were maintained and differentiated as described previously [<xref ref-type="bibr" rid="B10-ijms-21-05564">10</xref>,<xref ref-type="bibr" rid="B11-ijms-21-05564">11</xref>]. The hESC line, KhES-3 (XY genotype), was provided by Dr. Hirofumi Suemori, Research Center of Stem Cells, Institute for Frontier Medical Science, Kyoto University according to the NIES institutional guidelines for the use of human ES research [<xref ref-type="bibr" rid="B37-ijms-21-05564">37</xref>]. All experiments using hESCs were approved by the ethics committees of the National Institute for Environmental Studies and the University of Tokyo in accordance with the guidelines of the Japanese Ministry of Education, Culture, Sports, Science, and Technology. The procedures for the maintenance of hESCs were performed as described previously [<xref ref-type="bibr" rid="B37-ijms-21-05564">37</xref>,<xref ref-type="bibr" rid="B38-ijms-21-05564">38</xref>,<xref ref-type="bibr" rid="B39-ijms-21-05564">39</xref>]. MEFs were used as feeder cells for the culture and passage of the hESC line KhES3 in the DMEM/F12 media containing 20% KSR, 100 µM NEAA, 2 mM <sc>l</sc>-glutamine, 100 µM 2-ME, and 5 ng/mL bFGF. After five times of passages with additional MEFs, the MEFs were eliminated by a brief enzymatic treatment. The hESC colonies left on the dishes were harvested. The hESCs (purity &gt; 99%) were seeded at 9.0 × 10<sup>3</sup> cells/well in the medium containing DMEM/F12, 20% KSR, 100 µM NEAA, 2 mM <sc>l</sc>-glutamine, 100 µM 2-ME, and 10 µM of ROCK inhibitor Y-27632 (Day 1). The generated EBs were cultured for 7 days in the medium, which was exchanged every two days, followed by growth in the medium without Y-27632 for two days. The growing EBs were cultured for 2 additional days in NIM containing DMEM/F12: Neurobasal<sup>®</sup> Medium (1:1), N-2 Supplement, B-27<sup>®</sup> Supplement, GlutaMAX™-I, Penicillin-Streptomycin to promote neuronal differentiation. Then, EBs were re-plated onto O/L-coated 24-well-plates at 20 EBs/well. They were cultured for 7 days in neuronal proliferation medium (NPM) containing DMEM/F12: Neurobasal<sup>®</sup> Medium (1:1), two-fold concentrations of N-2 Supplement, two-fold concentrations of B-27<sup>®</sup> Supplement, GlutaMAX™-I, Penicillin-Streptomycin, 20 ng/mL bFGF. The medium was exchanged every 3 days. hESCs were allowed to form embryoid bodies (EBs) in the round bottom 96-well plate (Falcon 351177). The EBs were seeded onto ornithine–laminin (O/L)-coated 24-well plates to promote neuronal differentiation with the sequential exchange of authentic appropriate neuronal differentiation media every other day. The schedules for the formation of sphere and neuronal differentiation of hESCs are summarized in <xref ref-type="fig" rid="ijms-21-05564-f001">Figure 1</xref>A. Briefly, hESCs were allowed to form sphere in the round bottom 96 well plate for 7 days. Cells were exposed to each chemical from Day 3 to 7 during sphere formation. Doses of chemicals used here were within the clinical dose range for TMD, blood, urinary or breast milk concentrations reported in population studies for BPA, 4OH-PCB187 and BDE-47 [<xref ref-type="bibr" rid="B40-ijms-21-05564">40</xref>,<xref ref-type="bibr" rid="B41-ijms-21-05564">41</xref>,<xref ref-type="bibr" rid="B42-ijms-21-05564">42</xref>,<xref ref-type="bibr" rid="B43-ijms-21-05564">43</xref>,<xref ref-type="bibr" rid="B44-ijms-21-05564">44</xref>,<xref ref-type="bibr" rid="B45-ijms-21-05564">45</xref>]. The spheres were then seeded onto poly-ornithine/laminin 111-coated 24-well plates to promote proliferation and neuronal differentiation for 21 days, and the medium was refreshed every 3 days, as reported previously [<xref ref-type="bibr" rid="B11-ijms-21-05564">11</xref>].</p>
</sec>
<sec id="sec3dot3-ijms-21-05564">
<title>3.3. Immunocytochemistry and Image Analysis</title>
<p>Differentiated cells on day 28 were immunolabeled with human anti-MAP2 (M4403, 1:200, Sigma-Aldrich) or anti-TH (AB152, 1:200, Millipore, Burlington, MA, USA) antibodies, followed by staining with Alexa 546-conjugated secondary antibody (1:1000, Invitrogen, Carlsbad, CA, USA). The nuclei were stained with Hoechst 33,342 solution (Dojindo, Tokyo, Japan). The values for the area of fluorescent signals were analyzed using an IN Cell Analyzer 1000 (GE Healthcare UK Ltd., Buckinghamshire, UK), as previously reported [<xref ref-type="bibr" rid="B11-ijms-21-05564">11</xref>,<xref ref-type="bibr" rid="B46-ijms-21-05564">46</xref>]. In brief, immunofluorescent images were automatically acquired using the IN Cell Analyzer to quantify the differences in the cellular nuclei and cellular phenotypes. Fluorescent microphotographs (12 fields per well of a 24-well plate) were obtained automatically. Hoechst-positive nuclei and MAP2-positive or TH-positive neurites were recognized using IN Cell Developer Software. Removal of apoptotic or necrotic cells was performed by measuring the Hoechst-positive nuclei’s morphological features with nuclei fragmentation and chromatin condensation. Viable cells and apoptotic cells were classified according to nuclei size and the nuclei fluorescence signal density. The software was also used to identify neurons that stained positive with both nuclear stain and MAP2 antibodies, and to characterize the neurites extending from these cells. The length of the neurite for each identified cell was measured, respectively. Data were expressed as the mean neurite area per cell. Cells were cultured and stained in 6 independent wells for each condition, 12 fields per well were observed and values were calculated. Statistical analyses for cellular morphology were performed with Excel statistics (Microsoft 2016). All data were expressed relative to the means of the control groups. All results were represented as mean ± standard error (SE). All data were analyzed by one-way analysis of variance (ANOVA), followed by Fisher’s least significant difference (LSD) post hoc test, to compare the effect of each dose with the DMSO control groups. <italic>p</italic>-values less than 0.05 were considered statistically significant.</p>
</sec>
<sec id="sec3dot4-ijms-21-05564">
<title>3.4. Microarray Gene Expression Profiling</title>
<p>Four spheres from different experimental groups were pooled together separately. RNAs were isolated from each group on day 7. To detect changes in gene expression in spheres after the chemical exposure, microarray analyses were performed on the RNA sample using a microarray. Total RNA from spheres was isolated with the RNeasy Mini Kit (Qiagen, Hilden, Germany). Fifty nanograms of total RNA pooled from three independent samples was fluorescently labeled and hybridized to Agilent 8 × 60 K-Human Genome Microarrays (Sureprint G3 Human GE 8 × 60 K Ver.2.0 1color 4; Agilent Technologies Inc., Santa Clara, CA, USA). The arrays were hybridized and scanned in accordance with the manufacturer’s directions at the facility of Hokkaido System Science Co., Ltd. (Sapporo, Japan), as reported previously [<xref ref-type="bibr" rid="B10-ijms-21-05564">10</xref>]. The raw data was filtered based on signal intensity values and in the lowest 20 percentile and then filtered by FLAG-tag to remove entities that were not detected using GeneSpring GX12.10 software (Agilent Technologies Inc., Santa Clara, CA, USA). The microarray data were submitted to Gene Expression Omnibus (GEO) and registered as GSE151239 [<xref ref-type="bibr" rid="B47-ijms-21-05564">47</xref>].</p>
</sec>
<sec id="sec3dot5-ijms-21-05564">
<title>3.5. Knowledge-Based Pathway Analysis and Network Analysis</title>
<p>To explore the biological interpretation of the transcriptome data, the canonical pathway analysis, disease and bio-function annotation, and upstream causal network analysis were performed using the knowledge-based functional analysis software, Ingenuity Pathways Analysis (IPA, Ingenuity Systems, Redwood City, CA, USA). In IPA analysis, the fold change is a ratio (case/control), and it is up-regulated as it is between 1 and +infinity, and the value (x) between 0 and 1 is converted as “−1/x”. It is down-regulated with a distribution from −infinity to −1. Correlations of gene expression and morphological measures were calculated according to the Pearson correlation coefficients method in R Bioconductor (<uri xlink:href="https://www.bioconductor.org/">https://www.bioconductor.org/</uri>). Bayesian network analysis was applied based on using the TAO-Gen algorithm using the web-based RX-Taogen software (<uri xlink:href="http://extaogen.nies.go.jp/">http://extaogen.nies.go.jp/</uri>). The replicate exchange time was set as 20,000, as reported previously [<xref ref-type="bibr" rid="B39-ijms-21-05564">39</xref>]. The networks were visualized using the Gephi software (<uri xlink:href="https://gephi.org/">https://gephi.org/</uri>).</p>
</sec>
</sec>
<sec id="sec4-ijms-21-05564" sec-type="conclusions">
<title>4. Conclusions</title>
<p>The recent technology using three-dimensional neuronal sphere models derived from pluripotent stem cells has provided new insights into the etiology of neurological diseases and new therapeutic strategies for assessing chemical safety. In this study, we explored the comparative effects of TMD and environmental chemicals such as BDE47, BPA, and 4OH-PCB187 at realistic blood concentration levels on the neuronal differentiation of hESC-derived spheres. In conclusion, exposure to TMD, but not other chemicals, at the early stage of development influenced neuronal differentiation of MAP2-positive and TH-positive neuronal cells from hESC-derived spheres. Transcriptomic analysis and functional annotation at the early stage of neural differentiation showed specific TMD-induction genes associated with the ERK and synaptic signaling pathways. Computational network analysis of genetic and morphological actions of TMD during neuronal differentiation predicted that TMD-induced expression of DNA-binding protein inhibitor ID2 played an important role in neuronal development from hESC-derived spheres. These findings provide direct evidence that early transcriptomic changes during differentiation of hESCs by chemical exposure influenced neuronal development in later stages.</p>
</sec>
</body>
<back>
<app-group>
<app id="app1-ijms-21-05564">
<title>Supplementary Materials</title>
<p>Supplementary Materials can be found at <uri xlink:href="https://www.mdpi.com/1422-0067/21/15/5564/s1">https://www.mdpi.com/1422-0067/21/15/5564/s1</uri>. Figure S1: Effects of chemical exposure on cellular morphologies and <italic>MAP2</italic> gene expression during the neuronal differentiation from human embryonic stem cell (hESC)-derived spheres. Figure S2: Synaptogenesis Signaling Pathway. Figure S3: Upstream causal network. Figure S4: Representative network with probability values in Bayesian network analysis. Networks were generated based on the TAO-Gen algorithm using the web-based RX-Taogen software. Table S1: Lists of the TMD-specific genes selected after the comparison between TMD and each of the three chemicals correspondingly for IPA-pathway analysis. Table S2: Prediction of expression patterns of genes involved in the function of “Differentiation of embryonic cells” by IPA.</p>
<supplementary-material content-type="local-data" id="ijms-21-05564-s001">
<media xlink:href="ijms-21-05564-s001.zip">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</app>
</app-group>
<notes>
<title>Author Contributions</title>
<p>Conceptualization, H.S.; methodology, H.S., H.N. (Hiromi Nishikawa), H.N. (Hiroko Nansai).; software, H.S., X.-Y.Q. and M.K.; validation, H.S., X.-Y.Q. and T.I.; investigation, H.S. and H.N. (Hiromi Nishikawa), H.N. (Hiroko Nansai).; resources, H.S.; data curation, M.K. and Q.Y.; writing—original draft preparation, H.S., X.-Y.Q., T.I. and M.K.; writing—review and editing, H.S., X.-Y.Q., T.I. and M.K.; visualization, X.-Y.Q. and M.K.; supervision, H.S.; project administration, H.S.; funding acquisition, H.S. All authors have read and agreed to the published version of the manuscript. </p>
</notes>
<notes>
<title>Funding</title>
<p>This study was supported in part by the Environmental Technology Development Fund (to H.S.) from the Ministry of the Environment, and by a Grant-in-Aid for Scientific Research (A) (15H01749) by Japan Society for the Promotion of Science. </p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<glossary>
<title>Abbreviations</title>
<array orientation="portrait">
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">BDE-47</td>
<td align="left" colspan="1" rowspan="1" valign="middle">2,2′,4,4′-tetrabromodiphenyl ether</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">BPA</td>
<td align="left" colspan="1" rowspan="1" valign="middle">bisphenol A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">DMSO</td>
<td align="left" colspan="1" rowspan="1" valign="middle">dimethyl sulfoxide</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">hESC</td>
<td align="left" colspan="1" rowspan="1" valign="middle">human embryonic stem cell</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">4OH-PCB187</td>
<td align="left" colspan="1" rowspan="1" valign="middle">4-hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">TMD</td>
<td align="left" colspan="1" rowspan="1" valign="middle">thalidomide</td>
</tr>
</tbody>
</array>
</glossary>
<ref-list>
<title>References</title>
<ref id="B1-ijms-21-05564">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Thornicroft</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Baingana</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chisholm</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>P.Y.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Eaton</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Lancet Commission on global mental health and sustainable development</article-title>
<source/>Lancet
          <year>2018</year>
<volume>392</volume>
<fpage>1553</fpage>
<lpage>1598</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(18)31612-X</pub-id>
<pub-id pub-id-type="pmid">30314863</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-21-05564">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zablotsky</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>L.I.</given-names>
</name>
<name>
<surname>Maenner</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Schieve</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Blumberg</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Estimated Prevalence of Autism and Other Developmental Disabilities Following Questionnaire Changes in the 2014 National Health Interview Survey</article-title>
<source/>Natl. Health Stat. Rep.
          <year>2015</year>
<volume>13</volume>
<fpage>1</fpage>
<lpage>20</lpage>
</element-citation>
</ref>
<ref id="B3-ijms-21-05564">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pessah</surname>
<given-names>I.N.</given-names>
</name>
<name>
<surname>Seegal</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Lein</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>LaSalle</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Yee</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Van De Water</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Berman</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Immunologic and neurodevelopmental susceptibilities of autism</article-title>
<source/>Neurotoxicology
          <year>2008</year>
<volume>29</volume>
<fpage>532</fpage>
<lpage>545</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2008.02.006</pub-id>
<pub-id pub-id-type="pmid">18394707</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-21-05564">
<label>4.</label>
<element-citation publication-type="journal">
<article-title>Council on Environmental Health, Pesticide exposure in children</article-title>
<source/>Pediatrics
          <year>2012</year>
<volume>130</volume>
<fpage>e1757</fpage>
<lpage>e1763</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2012-2757</pub-id>
<pub-id pub-id-type="pmid">23184103</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-21-05564">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myhre</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Låg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Villanger</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Oftedal</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Øvrevik</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Holme</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Aase</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Paulsen</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Bal-Price</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dirven</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Early life exposure to air pollution particulate matter (PM) as risk factor for attention deficit/hyperactivity disorder (ADHD): Need for novel strategies for mechanisms and causalities</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <year>2018</year>
<volume>354</volume>
<fpage>196</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1016/j.taap.2018.03.015</pub-id>
<pub-id pub-id-type="pmid">29550511</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-21-05564">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Rahilly</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Significant features in the early prenatal development of the human brain</article-title>
<source/>Ann. Anat. Anat. Anz.
          <year>2008</year>
<volume>190</volume>
<fpage>105</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1016/j.aanat.2008.01.001</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-21-05564">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Radua</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Eisenhut</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gressier</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Koyanagi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Stubbs</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Solmi</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Environmental risk factors and biomarkers for autism spectrum disorder: An umbrella review of the evidence</article-title>
<source/>Lancet Psychiatry
          <year>2019</year>
<volume>6</volume>
<fpage>590</fpage>
<lpage>600</lpage>
<pub-id pub-id-type="doi">10.1016/S2215-0366(19)30181-6</pub-id>
<pub-id pub-id-type="pmid">31230684</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-21-05564">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Propson</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Engstrom</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>V.S.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Bolin</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human pluripotent stem cell-derived neural constructs for predicting, neural toxicity</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2015</year>
<volume>112</volume>
<fpage>12516</fpage>
<lpage>12521</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1516645112</pub-id>
<pub-id pub-id-type="pmid">26392547</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-21-05564">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Akanuma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>X.-Y.</given-names>
</name>
<name>
<surname>Imanishi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Toyoshiba</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yoshinaga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ohsako</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sone</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Multi-Parametric Profiling Network Based on Gene Expression and Phenotype Data: A Novel Approach to Developmental Neurotoxicity Testing</article-title>
<source/>Int. J. Mol. Sci.
          <year>2012</year>
<volume>13</volume>
<fpage>187</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="doi">10.3390/ijms13010187</pub-id>
<pub-id pub-id-type="pmid">22312247</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-21-05564">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pamies</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Block</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gribaldo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Barreras</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Smirnova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wiersma</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rotenone exerts developmental neurotoxicity in a human brain spheroid model</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <year>2018</year>
<volume>354</volume>
<fpage>101</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="doi">10.1016/j.taap.2018.02.003</pub-id>
<pub-id pub-id-type="pmid">29428530</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-21-05564">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Imanishi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sone</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nagano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>X.-Y.</given-names>
</name>
<name>
<surname>Yoshinaga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Akanuma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamane</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fujibuchi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ohsako</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of methylmercury exposure on neuronal differentiation of mouse and human embryonic stem cells</article-title>
<source/>Toxicol. Lett.
          <year>2012</year>
<volume>212</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2012.04.011</pub-id>
<pub-id pub-id-type="pmid">22555245</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-21-05564">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kurokawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Win-Shwe</surname>
<given-names>T.-T.</given-names>
</name>
<name>
<surname>Nansai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sone</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Effects of polyamidoamine dendrimers on a 3-D neurosphere system using human neural progenitor cells</article-title>
<source/>Toxicol. Sci.
          <year>2016</year>
<volume>152</volume>
<fpage>128</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfw068</pub-id>
<pub-id pub-id-type="pmid">27125967</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-21-05564">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katsura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cyou-Nakamine</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nansai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Amagasa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kanki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kaneki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Taguchi</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of Chronic Low-Dose Radiation on Human Neural Progenitor Cells</article-title>
<source/>Sci. Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>20027</fpage>
<pub-id pub-id-type="doi">10.1038/srep20027</pub-id>
<pub-id pub-id-type="pmid">26795421</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-21-05564">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>X.-Y.</given-names>
</name>
<name>
<surname>Akanuma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nagano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Imanishi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ohsako</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yoshinaga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yonemoto</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tanokura</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of low-dose thalidomide on dopaminergic neuronal differentiation of human neural progenitor cells: A combined study of metabolomics and morphological analysis</article-title>
<source/>NeuroToxicology
          <year>2012</year>
<volume>33</volume>
<fpage>1375</fpage>
<lpage>1380</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2012.08.016</pub-id>
<pub-id pub-id-type="pmid">22981892</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-21-05564">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyazaki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Narita</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Narita</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: Implication for pathogenesis of autism</article-title>
<source/>Int. J. Dev. Neurosci.
          <year>2005</year>
<volume>23</volume>
<fpage>287</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijdevneu.2004.05.004</pub-id>
<pub-id pub-id-type="pmid">15749253</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-21-05564">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rostamian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gharedaghi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Norouzi-Javidan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dehpour</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Involvement of the nitric oxide pathway in the anti-depressant-like effects of thalidomide in mice</article-title>
<source/>Physiol. Behav.
          <year>2019</year>
<volume>208</volume>
<fpage>112572</fpage>
<pub-id pub-id-type="doi">10.1016/j.physbeh.2019.112572</pub-id>
<pub-id pub-id-type="pmid">31175889</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-21-05564">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stoeckel</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Seitz</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Buetefisch</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<article-title>Congenitally altered motor experience alters somatotopic organization of human primary motor cortex</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>2395</fpage>
<lpage>2400</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0803733106</pub-id>
<pub-id pub-id-type="pmid">19164537</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-21-05564">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Strömland</surname>
<given-names>K.K.</given-names>
</name>
</person-group>
<article-title>What can we learn from the thalidomide experience</article-title>
<source/>Curr. Opin. Ophthalmol.
          <year>2011</year>
<volume>22</volume>
<fpage>356</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1097/ICU.0b013e3283499f24</pub-id>
<pub-id pub-id-type="pmid">21825994</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-21-05564">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hideshima</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shima</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Raje</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>F.E.</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Treon</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schlossman</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy</article-title>
<source/>Blood.
          <year>2000</year>
<volume>96</volume>
<fpage>2943</fpage>
<lpage>2950</lpage>
<pub-id pub-id-type="doi">10.1182/blood.V96.9.2943</pub-id>
<pub-id pub-id-type="pmid">11049970</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-21-05564">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donovan</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nowak</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>E.S.</given-names>
</name>
</person-group>
<article-title>Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome</article-title>
<source/>eLife
          <year>2018</year>
<volume>7</volume>
<fpage>e38430</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.38430</pub-id>
<pub-id pub-id-type="pmid">30067223</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-21-05564">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Seifikar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Larocque</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Khatib</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Abello</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Using a Multi-Stage hESC Model to Characterize BDE-47 Toxicity during Neurogenesis</article-title>
<source/>Toxicol. Sci.
          <year>2019</year>
<volume>171</volume>
<fpage>221</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfz136</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-21-05564">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaylord</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Osborne</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ghassabian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Malits</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Attina</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Trasande</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Trends in neurodevelopmental disability burden due to early life chemical exposure in the USA from 2001 to 2016: A population-based disease burden and cost analysis</article-title>
<source/>Mol. Cell. Endocrinol.
          <year>2020</year>
<volume>502</volume>
<fpage>110666</fpage>
<pub-id pub-id-type="doi">10.1016/j.mce.2019.110666</pub-id>
<pub-id pub-id-type="pmid">31952890</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-21-05564">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kundakovic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gudsnuk</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Herbstman</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>F.P.</given-names>
</name>
<name>
<surname>Champagne</surname>
<given-names>F.A.</given-names>
</name>
</person-group>
<article-title>DNA methylation of BDNF as a biomarker of early-life adversity</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2015</year>
<volume>112</volume>
<fpage>6807</fpage>
<lpage>6813</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1408355111</pub-id>
<pub-id pub-id-type="pmid">25385582</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-21-05564">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimura-Kuroda</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Disrupting effects of hydroxy-polychlorinated biphenyl (PCB) congeners on neuronal development of cerebellar Purkinje cells: A possible causal factor for developmental brain disorders?</article-title>
<source/>Chemosphere
          <year>2007</year>
<volume>67</volume>
<fpage>S412</fpage>
<lpage>S420</lpage>
<pub-id pub-id-type="doi">10.1016/j.chemosphere.2006.05.137</pub-id>
<pub-id pub-id-type="pmid">17223178</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-21-05564">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grandjean</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Landrigan</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Neurobehavioural effects of developmental toxicity</article-title>
<source/>Lancet Neurol.
          <year>2014</year>
<volume>13</volume>
<fpage>330</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(13)70278-3</pub-id>
<pub-id pub-id-type="pmid">24556010</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-21-05564">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haraguchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takagi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Koizumi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Levels, profiles and dietary sources of hydroxylated PCBs and hydroxylated and methoxylated PBDEs in Japanese women serum samples</article-title>
<source/>Environ. Int.
          <year>2016</year>
<volume>97</volume>
<fpage>155</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1016/j.envint.2016.08.022</pub-id>
<pub-id pub-id-type="pmid">27615405</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-21-05564">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>McAlonan</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Schantz</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Effects of Developmental Exposure to Polychlorinated Biphenyls and/or Polybrominated Diphenyl Ethers on Cochlear Function</article-title>
<source/>Toxicol. Sci.
          <year>2011</year>
<volume>124</volume>
<fpage>161</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfr214</pub-id>
<pub-id pub-id-type="pmid">21873374</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-21-05564">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meganathan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jagtap</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wagh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gaspar</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Hildebrand</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Trusch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hescheler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schlüter</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>e44228</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0044228</pub-id>
<pub-id pub-id-type="pmid">22952932</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-21-05564">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schreiber</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gassmann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Götz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hübenthal</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Moors</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Krause</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Merk</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Scanlan</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Abel</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Polybrominated diphenyl ethers induce developmental neurotoxicity in a human in vitro model: Evidence for endocrine disruption</article-title>
<source/>Environ. Health Perspect.
          <year>2010</year>
<volume>118</volume>
<fpage>572</fpage>
<lpage>578</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.0901435</pub-id>
<pub-id pub-id-type="pmid">20368126</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-21-05564">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>PTEN promotes dopaminergic neuronal differentiation through regulation of erk-dependent inhibition of s6k signaling in human neural stem cells</article-title>
<source/>Stem Cells Transl. Med.
          <year>2016</year>
<volume>5</volume>
<fpage>1319</fpage>
<lpage>1329</lpage>
<pub-id pub-id-type="doi">10.5966/sctm.2015-0200</pub-id>
<pub-id pub-id-type="pmid">27388240</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-21-05564">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>X.-Y.</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Arner</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kawaguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tatsukawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Furutani</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nagatsuma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsuura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes</article-title>
<source/>EBioMedicine
          <year>2017</year>
<volume>24</volume>
<fpage>257</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1016/j.ebiom.2017.09.008</pub-id>
<pub-id pub-id-type="pmid">28927749</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-21-05564">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Libbrecht</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Noble</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>Machine Learning Applications in Genetics and Genomics</article-title>
<source/>Nat. Rev. Genet.
          <year>2015</year>
<volume>16</volume>
<fpage>321</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3920</pub-id>
<pub-id pub-id-type="pmid">25948244</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-21-05564">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Faiola</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Typical halogenated flame retardants affect human neural stem cell gene expression during proliferation and differentiation via glycogen synthase kinase 3 beta and T3 signaling</article-title>
<source/>Ecotoxicol. Environ. Saf.
          <year>2019</year>
<volume>183</volume>
<fpage>109498</fpage>
<pub-id pub-id-type="doi">10.1016/j.ecoenv.2019.109498</pub-id>
<pub-id pub-id-type="pmid">31377521</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-21-05564">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Faiola</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Bisphenol A and several derivatives exert neural toxicity in human neuron-like cells by decreasing neurite length</article-title>
<source/>Food Chem. Toxicol.
          <year>2020</year>
<volume>135</volume>
<fpage>111015</fpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2019.111015</pub-id>
<pub-id pub-id-type="pmid">31812737</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-21-05564">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Effects of environmental chemicals on the proliferation and differentiation of neural stem cells</article-title>
<source/>Environ. Toxicol.
          <year>2019</year>
<volume>34</volume>
<fpage>1285</fpage>
<lpage>1291</lpage>
<pub-id pub-id-type="doi">10.1002/tox.22829</pub-id>
<pub-id pub-id-type="pmid">31400064</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-21-05564">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caspersen</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Aase</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Biele</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Brantsæter</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Haugen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kvalem</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Skogan</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Zeiner</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>H.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The influence of maternal dietary exposure to dioxins and PCBs during pregnancy on ADHD symptoms and cognitive functions in Norwegian preschool children</article-title>
<source/>Environ. Int.
          <year>2016</year>
<volume>94</volume>
<fpage>649</fpage>
<lpage>660</lpage>
<pub-id pub-id-type="doi">10.1016/j.envint.2016.06.033</pub-id>
<pub-id pub-id-type="pmid">27424260</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-21-05564">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suemori</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yasuchika</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fujioka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tsuneyoshi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nakatsuji</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2006</year>
<volume>345</volume>
<fpage>926</fpage>
<lpage>932</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2006.04.135</pub-id>
<pub-id pub-id-type="pmid">16707099</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-21-05564">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimizukawa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sakata</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hirose</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iseki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kunita</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yagami</surname>
<given-names>K.-I.</given-names>
</name>
</person-group>
<article-title>Establishment of a new embryonic stem cell line derived from C57BL/6 mouse expressing EGFP ubiquitously</article-title>
<source/>Genesis
          <year>2005</year>
<volume>42</volume>
<fpage>47</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1002/gene.20122</pub-id>
<pub-id pub-id-type="pmid">15830376</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-21-05564">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamane</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Aburatani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Imanishi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Akanuma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nagano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sone</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ohsako</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fujibuchi</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Prediction of developmental chemical toxicity based on gene networks of human embryonic stem cells</article-title>
<source/>Nucleic Acids Res.
          <year>2016</year>
<volume>44</volume>
<fpage>5515</fpage>
<lpage>5528</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkw450</pub-id>
<pub-id pub-id-type="pmid">27207879</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-21-05564">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darras</surname>
<given-names>V.M.</given-names>
</name>
</person-group>
<article-title>Endocrine disrupting polyhalogenated organic pollutants interfere with thyroid hormone signalling in the developing brain</article-title>
<source/>Cerebellum
          <year>2008</year>
<volume>7</volume>
<fpage>26</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1007/s12311-008-0004-5</pub-id>
<pub-id pub-id-type="pmid">18418666</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-21-05564">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mustieles</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pérez-Lobato</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Olea</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fernández</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Bisphenol A: Human exposure and neurobehavior</article-title>
<source/>NeuroToxicology
          <year>2015</year>
<volume>49</volume>
<fpage>174</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2015.06.002</pub-id>
<pub-id pub-id-type="pmid">26121921</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-21-05564">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mercogliano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Santonicola</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Investigation on bisphenol A levels in human milk and dairy supply chain: A review</article-title>
<source/>Food Chem. Toxicol.
          <year>2018</year>
<volume>114</volume>
<fpage>98</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2018.02.021</pub-id>
<pub-id pub-id-type="pmid">29448092</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-21-05564">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berghuis</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Soechitram</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Hitzert</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Sauer</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Bos</surname>
<given-names>A.F.</given-names>
</name>
</person-group>
<article-title>Prenatal exposure to polychlorinated biphenyls and their hydroxylated metabolites is associated with motor development of three-month-old infants</article-title>
<source/>NeuroToxicology
          <year>2013</year>
<volume>38</volume>
<fpage>124</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2013.07.003</pub-id>
<pub-id pub-id-type="pmid">23895877</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-21-05564">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaspers</surname>
<given-names>V.L.B.</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sonne</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Letcher</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Eens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Neels</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Born</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Covaci</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A screening of persistent organohalogenated contaminants in hair of East Greenland polar bears</article-title>
<source/>Sci. Total Environ.
          <year>2010</year>
<volume>408</volume>
<fpage>5613</fpage>
<lpage>5618</lpage>
<pub-id pub-id-type="doi">10.1016/j.scitotenv.2010.07.059</pub-id>
<pub-id pub-id-type="pmid">20800875</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-21-05564">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>J.-S.</given-names>
</name>
<name>
<surname>Bergman</surname>
<given-names>Å.</given-names>
</name>
<name>
<surname>Linderholm</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Athanasiadou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kočan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Petřík</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Drobna</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Trnovec</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Charles</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname> Hertz-Picciotto</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Placental transfer of polychlorinated biphenyls, their hydroxylated metabolites and pentachlorophenol in pregnant women from eastern Slovakia</article-title>
<source/>Chemosphere
          <year>2008</year>
<volume>70</volume>
<fpage>1676</fpage>
<lpage>1684</lpage>
<pub-id pub-id-type="doi">10.1016/j.chemosphere.2007.07.049</pub-id>
<pub-id pub-id-type="pmid">17764717</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-21-05564">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kurokawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Win-Shwe</surname>
<given-names>T.-T.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Hirano</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sone</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sone</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Effects of PAMAM dendrimers with various surface functional groups and multiple generations on cytotoxicity and neuronal differentiation using human neural progenitor cells</article-title>
<source/>J. Toxicol. Sci.
          <year>2016</year>
<volume>41</volume>
<fpage>351</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="doi">10.2131/jts.41.351</pub-id>
<pub-id pub-id-type="pmid">27193728</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-21-05564">
<label>47.</label>
<element-citation publication-type="gov">
<person-group person-group-type="author">
<name>
<surname>Sone</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Comparative Analysis between Effects of Thalidomide and Environmental Chemicals on Neuronal Differentiations in Human Sphere</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE151239">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE151239</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2020-05-28">(accessed on 28 May 2020)</date-in-citation>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-21-05564-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Morphological analysis of the effect of chemical exposure on neuronal differentiation from human embryonic stem cell (hESC)-derived spheres. (<bold>A</bold>) Experimental protocol of sphere formation and neuronal differentiation from hESCs. Dose-dependent effects of exposure to (<bold>B</bold>) thalidomide (TMD), (<bold>C</bold>) 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47), (<bold>D</bold>) bisphenol A (BPA), and (<bold>E</bold>) 4-hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl (4OH-PCB187) at the early stage of development on the number of cell nuclei and microtubule-associated protein 2 (MAP2)-positive and tyrosine hydroxylase (TH)-positive areas during neuronal differentiation from hESC-derived spheres. The data are represented as mean ± standard deviation of at least three biological replicates. * <italic>p</italic> &lt; 0.05, analysis of variance (ANOVA) test.</p>
</caption>
<graphic xlink:href="ijms-21-05564-g001"></graphic>
</fig>
<fig id="ijms-21-05564-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Transcriptome analysis of the effect of chemical exposure on gene expression in hESC-derived spheres. (<bold>A</bold>) Summary of the number and (<bold>B</bold>) functional annotation of differentially expressed genes in hESC-derived spheres after exposure to 1 μM TMD, 0.01 μM BDE47, 0.1 μM BPA, and 0.01 μM 4OH-PCB187. (<bold>C</bold>) Canonical pathway analysis of differentially expressed genes generated using the knowledge-based functional analysis software Ingenuity Pathways Analysis (IPA). (<bold>D</bold>) Expression of enriched genes involved in the synaptogenesis signaling pathway.</p>
</caption>
<graphic xlink:href="ijms-21-05564-g002"></graphic>
</fig>
<fig id="ijms-21-05564-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>TMD-specific effect on gene expression in hESC-derived spheres. (<bold>A</bold>) Comparison of differentially expressed genes in hESC-derived spheres upon exposure to 1 μM TMD, 0.01 μM BDE47, 0.1 μM BPA, or 0.01 μM 4OH-PCB187. The red number indicates TMD-specific genes. (<bold>B</bold>) The biological functions of the top populated networks generated in IPA associated with differentially expressed genes specifically induced by TMD exposure. (<bold>C</bold>) A representative network related to neurogenesis entitled “Neurological Disease, Organismal Injury and Abnormalities, Cell Morphology”. Upregulated genes under control of TMD are indicated in red symbols, downregulated genes under control of TMD indicated in green symbols, and genes that were not annotated in this study, but are part of this network were indicated in white symbols. Solid lines indicate direct relationships, and dotted lines indicate indirect gene-gene relationships within the represented network. (<bold>D</bold>) The biological pathways of embryonic development generated in IPA were ranked by z-score, which can be used to find the likely regulating molecules based on a statistically significant pattern match of up- and down-regulation, and also to predict the activation state (activated or inhibited) of a putative regulator. (<bold>E</bold>) Expression of enriched genes involved in the “Differentiation of embryonic cells” pathway.</p>
</caption>
<graphic xlink:href="ijms-21-05564-g003"></graphic>
</fig>
<fig id="ijms-21-05564-f004" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>Integrated network analysis of transcriptomic and morphological changes during neuronal differentiation from hESC-derived spheres. (<bold>A</bold>) Pearson correlation analysis. The links with an absolute Pearson correlation coefficient of more than 0.7 are shown. The network was visualized using Gephi software. (<bold>B</bold>) Bayesian network analysis. The network was generated based on the TAO-Gen algorithm using the web-based RX-Taogen software and was visualized using Gephi software. The β-value of the Bayesian model is expressed as a red arrow if positively relative (β &gt; 1), and a blue arrow if negatively relative (β &lt; 1). (<bold>C</bold>) Physiological network generated using the Ingenuity Knowledge Base of the IPA software. Upregulated genes induced by TMD exposure are indicated in red symbols that are representing molecules. The solid line indicates direct interactions gene-gene association. Dot lines indicate indirect interactions to “Neurogenesis” or “Differentiation of embryonic stem cells”.</p>
</caption>
<graphic xlink:href="ijms-21-05564-g004"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>